Myomo (MYO) Net Income towards Common Stockholders (2016 - 2025)
Myomo posted quarterly Net Income towards Common Stockholders of -$3.7 million for Q3 2025, down 279.02% year-on-year from $2.0 million in Q3 2024, and up 20.92% on a QoQ basis from -$4.6 million in Q2 2025.
Myomo (MYO) has 10 years of Net Income towards Common Stockholders data on file, last reported at -$3.7 million in Q3 2025.
- For the quarter ending Q3 2025, Net Income towards Common Stockholders fell 279.02% year-over-year to -$3.7 million; the trailing twelve-month figure through Dec 2025 stood at -$11.8 million (down 1934.5% YoY), and the FY2024 full-year result was $641042.0, up 12.62% from the prior year.
- Net Income towards Common Stockholders for Q3 2025 stood at -$3.7 million, up from -$4.6 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $6.6 million in Q4 2024 and bottomed at -$4.6 million in Q2 2025.
- The 5-year median for Net Income towards Common Stockholders is -$2.6 million (2023), against an average of -$1.7 million.
- The widest annual swing landed in 2023, when Net Income towards Common Stockholders soared 366.45%; it then slumped 312.98% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$3.4 million in 2021, then jumped by 30.39% to -$2.3 million in 2022, then jumped by 366.45% to $6.3 million in 2023, then gained by 4.92% to $6.6 million in 2024, then slumped by 155.8% to -$3.7 million in 2025.
- The last three Net Income towards Common Stockholders figures came in at -$3.7 million (Q3 2025), -$4.6 million (Q2 2025), and -$3.5 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3.66 Mn |
| Jun 30, 2025 | -4.63 Mn |
| Mar 31, 2025 | -3.47 Mn |
| Dec 31, 2024 | 6.56 Mn |
| Sep 30, 2024 | -966,409.00 |
| Jun 30, 2024 | -1.12 Mn |
| Mar 31, 2024 | -3.84 Mn |
| Dec 31, 2023 | 6.26 Mn |
| Sep 30, 2023 | -2.03 Mn |
| Jun 30, 2023 | -1.01 Mn |
| Mar 31, 2023 | -2.64 Mn |
| Dec 31, 2022 | -2.35 Mn |
| Sep 30, 2022 | -2.83 Mn |
| Jun 30, 2022 | -2.91 Mn |
| Mar 31, 2022 | -2.81 Mn |
| Dec 31, 2021 | -3.37 Mn |
| Sep 30, 2021 | -2.06 Mn |
| Jun 30, 2021 | -2.62 Mn |
| Mar 31, 2021 | -2.96 Mn |
| Dec 31, 2020 | -1.70 Mn |
| Sep 30, 2020 | -2.78 Mn |
| Jun 30, 2020 | -3.29 Mn |
| Mar 31, 2020 | -4.47 Mn |
| Dec 31, 2019 | -2.76 Mn |
| Sep 30, 2019 | -2.79 Mn |
| Jun 30, 2019 | -2.57 Mn |
| Mar 31, 2019 | -3.40 Mn |
| Dec 31, 2018 | -2.69 Mn |
| Sep 30, 2018 | -2.65 Mn |
| Jun 30, 2018 | -2.63 Mn |
| Mar 31, 2018 | -2.35 Mn |
| Dec 31, 2017 | -1.90 Mn |
| Sep 30, 2017 | -1.26 Mn |
| Jun 30, 2017 | -7.75 Mn |
| Mar 31, 2017 | -1.75 Mn |
| Dec 31, 2016 | -1.40 Mn |
| Sep 30, 2016 | -1.21 Mn |
| Jun 30, 2016 | -950,745.00 |